Comparison of Laparoscopic and Open Inguinal Hernia Repair in Elderly Patients
Launched by MEHMET EŞREF ULUTAŞ · May 11, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods of surgery for inguinal hernias in older patients—specifically, those who are 65 years and older. It aims to compare laparoscopic surgery, which uses small incisions and is known for quicker recovery, with open surgery, which involves a larger incision but can be done with local anesthesia. The goal is to determine which method is safer and more effective for elderly patients, especially considering their unique health needs.
To be eligible for this trial, participants must be over 65 years old and have an inguinal hernia. However, those under 65 or with more severe hernia complications won’t be included. If you decide to participate, you can expect to play a role in helping researchers understand which surgical approach is better for older adults, potentially improving care for future patients. The study is currently recruiting participants, and it’s a chance to contribute to important medical research while receiving care for a common surgical issue.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with inguinal hernias.
- • Patients aged over 65.
- Exclusion Criteria:
- • Younger than 65 years.
- • Incarcerated or strangulated inguinal hernias.
About Mehmet Eşref Ulutaş
Mehmet Eşref Ulutaş is a distinguished clinical trial sponsor known for his commitment to advancing medical research and innovation. With a focus on ensuring the highest standards of ethical practice and scientific rigor, he leads initiatives that facilitate the development of novel therapies and treatments. His expertise in clinical trial design and execution has contributed to significant advancements in patient care, making him a pivotal figure in the healthcare research community. Through collaboration with various stakeholders, Ulutaş aims to bridge the gap between scientific discovery and practical application, ultimately enhancing the efficacy and accessibility of healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Van, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported